Association of Nonsteroidal Anti-inflammatory Drug Use With Stroke Among Dialysis Patients

Patrono, 2014, Nonsteroidal anti-inflammatory drugs and the heart, Circulation, 129, 907, 10.1161/CIRCULATIONAHA.113.004480 Solomon, 2005, Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention, N Engl J Med, 352, 1071, 10.1056/NEJMoa050405 Bresalier, 2005, Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial, N Engl J Med, 352, 1092, 10.1056/NEJMoa050493 Andersohn, 2006, Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study, Stroke, 37, 1725, 10.1161/01.STR.0000226642.55207.94 Antman, 2007, Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association, Circulation, 115, 1634, 10.1161/CIRCULATIONAHA.106.181424 Toyoda, 2004, Incidence, etiology, and outcome of stroke in patients on continuous ambulatory peritoneal dialysis, Cerebrovasc Dis, 17, 98, 10.1159/000075776 Toyoda, 2005, Stroke in patients on maintenance hemodialysis: a 22-year single-center study, Am J Kidney Dis, 45, 1058, 10.1053/j.ajkd.2005.02.028 Seliger, 2003, Elevated risk of stroke among patients with end-stage renal disease, Kidney Int, 64, 603, 10.1046/j.1523-1755.2003.00101.x Kristensen, 2012, Use of nonsteroidal anti-inflammatory drugs prior to chronic renal replacement therapy initiation: a nationwide study, Pharmacoepidemiol Drug Saf, 21, 428, 10.1002/pds.3227 Hsu, 2015, Use of nonsteroidal anti-inflammatory drugs and risk of chronic kidney disease in subjects with hypertension: Nationwide Longitudinal Cohort Study, Hypertension, 66, 524, 10.1161/HYPERTENSIONAHA.114.05105 Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: World Health Organization, 2009. Chang, 2010, Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study, Stroke, 41, 1884, 10.1161/STROKEAHA.110.585828 Chuang, 2015, Association of short-term use of nonsteroidal anti-inflammatory drugs with stroke in patients with hypertension, Stroke, 46, 996, 10.1161/STROKEAHA.114.007932 Gislason, 2006, Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction, Circulation, 113, 2906, 10.1161/CIRCULATIONAHA.106.616219 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Haag, 2008, Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke, Arch Intern Med, 168, 1219, 10.1001/archinte.168.11.1219 Fosbol, 2014, Use of nonsteroidal anti-inflammatory drugs among healthy people and specific cerebrovascular safety, Int J Stroke, 9, 943, 10.1111/j.1747-4949.2012.00863.x Caughey, 2011, Stroke risk and NSAIDs: an Australian population-based study, Med J Aust, 195, 525, 10.5694/mja11.10055 Trelle, 2011, Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis, BMJ, 342, c7086, 10.1136/bmj.c7086 Bak, 2003, Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study, Stroke, 34, 379, 10.1161/01.STR.0000053029.45352.A0 Choi, 2008, Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis study, Stroke, 39, 845, 10.1161/STROKEAHA.107.497040 Mangoni, 2010, Use of non-steroidal anti-inflammatory drugs and risk of ischemic and hemorrhagic stroke in the Australian veteran community, Pharmacoepidemiol Drug Saf, 19, 490 Schwartz, 2000, Patients' perceptions of route of nonsteroidal anti-inflammatory drug administration and its effect on analgesia, Acad Emerg Med, 7, 857, 10.1111/j.1553-2712.2000.tb02061.x Tziomalos, 2015, Effects of different classes of antihypertensive agents on the outcome of acute ischemic stroke, J Clin Hypertens (Greenwich), 17, 275, 10.1111/jch.12498 Yoshii, 2014, Effects of pioglitazone on macrovascular events in patients with type 2 diabetes mellitus at high risk of stroke: the PROFIT-J study, J Atheroscler Thromb, 21, 563 Whelton, 2001, Cyclooxygenase-2—specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients, Am J Ther, 8, 85, 10.1097/00045391-200103000-00003 Amer, 2010, Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale, Cardiol Rev, 18, 204, 10.1097/CRD.0b013e3181ce1521 Brater, 2001, Renal effects of COX-2-selective inhibitors, Am J Nephrol, 21, 1, 10.1159/000046212 Smith, 2000, Cyclooxygenases: structural, cellular, and molecular biology, Annu Rev Biochem, 69, 145, 10.1146/annurev.biochem.69.1.145 Whelton, 2002, Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis, Am J Cardiol, 90, 959, 10.1016/S0002-9149(02)02661-9 Jaimes, 2010, Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress, Am J Physiol Renal Physiol, 298, F125, 10.1152/ajprenal.00248.2009 Green, 2012, The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function, Curr Opin Nephrol Hypertens, 21, 7, 10.1097/MNH.0b013e32834d9d75 1994, Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ, 308, 81, 10.1136/bmj.308.6921.81 Garcia Rodriguez, 2000, Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women, Epidemiology, 11, 382, 10.1097/00001648-200007000-00004 Catella-Lawson, 2001, Cyclooxygenase inhibition and thrombogenicity, Am J Med, 110, 28S, 10.1016/S0002-9343(00)00683-5 Caughey, 2001, Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2, J Immunol, 167, 2831, 10.4049/jimmunol.167.5.2831 Garella, 1984, Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents, Medicine, 63, 165, 10.1097/00005792-198405000-00003 Brater, 1999, Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition, Am J Med, 107, 65S, 10.1016/S0002-9343(99)00369-1 Brater, 2002, Anti-inflammatory agents and renal function, Semin Arthritis Rheum, 32, 33, 10.1053/sarh.2002.37216